Neurological Disease Biotech

Market Movers
Minimally-Invasive
Minimally-Invasive Medical devices
Neurological Disease Biotech

ClearPoint Neuro, Inc. (CLPT): The Future of Neurological Treatment

Featured Content ClearPoint Neuro, Inc. (CLPT) is a company specializing in advanced neurosurgical solutions that help surgeons perform minimally invasive brain procedures with greater precision and accuracy. Their standout product is the ClearPoint Neuro Navigation System, which enables real-time guidance for surgeons during brain surgeries. This platform provides high-quality imaging and navigation, allowing surgeons to […]

Read More
Biopharmaceuticals
Market Movers
Neurological Disease Biotech
Pharmaceuticals

Longboard Pharmaceuticals, Inc. (LBPH): Strategic Growth in the Neurology Market

Longboard Pharmaceuticals, Inc. (LBPH) is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurological diseases. The company’s mission is to bring innovative treatments to patients suffering from debilitating neurological conditions with limited or no treatment options. Longboard’s pipeline is centered around proprietary compounds designed to target specific receptors in the central nervous system, […]

Read More
Daily Rundown
Fine Jewelry
Neurological Disease Biotech
Organ Care System (OCS)
Real Estate Financing
Role-based Analytics Platform

Fine Jewelry, Role-based Analytics Platform, Organ Care System (OCS), Neurological Disease Biotech, Real Estate Financing

Charles & Colvard, Ltd. (CTHR) Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and […]

Read More